Litcius/Paper detail

Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study

Amyn A. Malik, Saira Farooq, Maria Jaswal, Hiba Khan, Kumail Nasir, Usama Fareed, Shumail Shahbaz, Farhana Amanullah, Nauman Safdar, Aamir Khan, Salmaan Keshavjee, Mercedes C. Becerra, Hamidah Hussain

2021The Lancet Child & Adolescent Health30 citationsDOI

Topics & Concepts

RifapentineMedicineIsoniazidTuberculosisProspective cohort studyCohortCohort studyPediatricsInternal medicineMycobacterium tuberculosisLatent tuberculosisPathologyTuberculosis Research and EpidemiologyPharmaceutical studies and practicesMalaria Research and Control